Patents by Inventor Susanna ROLL

Susanna ROLL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HIGH DOSE AND LOW VOLUME BOTULINUM TOXIN TREATMENT OF FACIAL WRINKLES
    Publication number: 20230329996
    Abstract: The present invention relates the use of botulinum toxin for the treatment of facial wrinkles, wherein botulinum toxin is administered at high doses (e.g., 50 U to 200 U) using small injection volumes (e.g., 0.05 ml to 0.35 ml). Furthermore, the present invention relates to a method for the treatment of facial wrinkles (e.g., glabellar frown lines) by injecting small volumes of a highly concentrated botulinum toxin solution into a target facial area of a subject.
    Type: Application
    Filed: June 4, 2021
    Publication date: October 19, 2023
    Inventors: Susanna ROLL, Meik SLADEK, Thorin GEISTER, Irena PULTE, Petra WEISSENBERGER, Gudrun KLEIN
  • USE OF RECOMBINANT CLOSTRIDIAL NEUROTOXINS FOR THE TREATMENT OF PATIENTS HAVING CERTAIN MUSCLE-RELATED DISORDERS
    Publication number: 20170189500
    Abstract: This invention relates to novel uses of recombinant clostridial neurotoxins exhibiting decreased duration of effect, in particular uses for the treatment of patients having experienced muscle-related disorders and/or injuries.
    Type: Application
    Filed: June 12, 2015
    Publication date: July 6, 2017
    Inventors: Klaus FINK, Susanne GRAFE, Imke SCHULTZ, Susanna ROLL, Deryck JORDAN
  • NOVEL USES OF RECOMBINANT CLOSTRIDIAL NEUROTOXINS WITH DECREASED DURATION OF EFFECT
    Publication number: 20170128551
    Abstract: This invention relates to novel uses of recombinant clostridial neurotoxins exhibiting decreased duration of effect, in particular uses for the treatment of patients suffering from a limited range of muscle extension, in particular from flexion contracture, in particular flexion contracture of the knee, and more particularly uses for the treatment of such patients having experienced a total knee arthroplasty.
    Type: Application
    Filed: June 12, 2015
    Publication date: May 11, 2017
    Inventors: Klaus FINK, Susanne GRAFE, Imke SCHULTZ, Susanna ROLL
  • NOVEL USES OF RECOMBINANT CLOSTRIDIAL NEUROTOXINS WITH DECREASED DURATION OF EFFECT
    Publication number: 20170119863
    Abstract: This invention relates to novel uses of recombinant clostridial neurotoxins exhibiting decreased duration of effect, in particular uses for the treatment of patients having experienced tendon-related disorders and/or injuries.
    Type: Application
    Filed: June 12, 2015
    Publication date: May 4, 2017
    Inventors: Klaus FINK, Susanne GRAFE, Imke SCHULTZ, Susanna ROLL